首页> 外文期刊>Fertility and Sterility: Official Journal of the American Fertility Society, Pacific Coast Fertility Society, and the Canadian Fertility and Andrology Society >Sperm content of postacrosomal WW binding protein is related to fertilization outcomes in patients undergoing assisted reproductive technology
【24h】

Sperm content of postacrosomal WW binding protein is related to fertilization outcomes in patients undergoing assisted reproductive technology

机译:辅助生殖技术患者的顶体后WW结合蛋白的精子含量与受精结果有关

获取原文
获取原文并翻译 | 示例
           

摘要

Objective To determine the levels of postacrosomal WW binding protein (PAWP) in the spermatozoa of men that were used clinically for intracytoplasmic sperm injection (ICSI) and to correlate them with infertility treatment outcomes. Design Prospective clinical and laboratory study. Setting University-based laboratory and infertility clinic. Patient(s) Men undergoing ICSI for the treatment of couples' infertility (n = 110). Intervention(s) Quantitative analysis of sperm PAWP levels by flow cytometry and developmental analysis of PAWP expression by immunoblotting, immunofluorescence, and immunohistochemistry. Main Outcome Measure(s) PAWP flow-cytometric levels and immunolocalization in spermatozoa. Result(s) A strong positive correlation was found between PAWP expression levels and fertilization rates after ICSI, with high levels of PAWP being associated with higher fertilization rates; the positive correlation was independent of age, DNA fragmentation index, and other sperm parameters. PAWP expression levels were correlated with embryonic development, with high levels of PAWP being associated with a lower number of arrested embryos within 3-5 days post-ICSI. PAWP expression was detected during the late stages of human spermiogenesis in elongating spermatids, confirming previous findings in various animal models. Conclusion(s) Our clinical data from infertile couples demonstrate significant correlations between sperm PAWP levels and both fertilization rates and normal embryonic development after ICSI. Considering its proposed role in the initiation of oocyte activation, we suggest that PAWP could have potential applications in the diagnosis and treatment of infertility.
机译:目的确定临床上用于胞浆内精子注射(ICSI)的男性精子中的血清后WW结合蛋白(PAWP)水平,并将其与不育治疗结果相关联。设计前瞻性临床和实验室研究。设立以大学为基地的实验室和不孕诊所。正在接受ICSI治疗的夫妻不育症的男性患者(n = 110)。干预通过流式细胞术对精子PAWP水平进行定量分析,并通过免疫印迹,免疫荧光和免疫组织化学对PAWP表达进行发育分析。主要观察指标精子中PAWP流式细胞仪水平和免疫定位。结果ICSI后PAWP表达水平与受精率之间存在很强的正相关关系,高PAWP水平与较高的受精率有关。正相关与年龄,DNA碎片指数和其他精子参数无关。 PAWP表达水平与胚胎发育相关,高水平PAWP与ICSI后3-5天内被捕的胚胎数量减少有关。在人类精子形成后期精子细胞延长过程中检测到PAWP表达,这证实了先前在各种动物模型中的发现。结论我们的不育夫妇的临床数据表明,ICSI后精子PAWP水平与受精率和正常胚胎发育之间存在显着相关性。考虑到它在卵母细胞活化启动中的作用,我们建议PAWP可能在不孕症的诊断和治疗中具有潜在的应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号